首页 >
法规速递
-
国家药监局关于发布优化全生命周期监管支持高端医疗器械创新发展有关举措的公告（2025年第63号）-2025/7/3
2025-07-04查看详情 > -
Document: Annex I - Use of titanium dioxide as excipient in human and veterinary medicines and identification of alternatives - Industry feedback to QWP experts / EMA questions - Final report February 2024-2025/8/6
2025-08-07查看详情 > -
Document: List of medicinal products under additional monitoring-2025/9/24
2025-09-25查看详情 > -
Page: COVID-19 vaccines: key facts-2025/10/31
2025-11-03查看详情 > -
Document: Agenda - HMA/EMA Annual Data Forum 2025-2025/12/1
2025-12-02查看详情 > -
Document: Report - Industry stakeholder feedback on engagement and communication activities-2026/1/5
2026-01-06查看详情 > -
Document: PhV non-compliance notification contact points at National Competent Authority (NCA) level-2026/2/9
2026-02-10查看详情 > -
Document: Network Portfolio Roadmap-2026/3/18
2026-03-19查看详情 > -
Document: Process for the electronic submission of medicinal product information - Chapter 3-2026/4/21
2026-04-22查看详情 > -
国家药监局药审中心关于发布《真实世界证据支持药物注册申请的沟通交流指导原则（试行）》的通告（2023年第6号）-2023/02/16
2023-02-16查看详情 >
